Increased serum amiodarone concentration in hypertriglyceridemic patients: Effects of drug distribution to serum lipoproteins-Reference-Cited by-同舟云学术

Increased serum amiodarone concentration in hypertriglyceridemic patients: Effects of drug distribution to serum lipoproteins

Published:2021-11-25 Issue: Volume: Page:
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Hashimoto Naoaki¹²,Doki Kosuke¹²,Kawano Satoru³,Aonuma Kazutaka³,Ieda Masaki³,Homma Masato¹²

Affiliation:

1. Department of Pharmacy University of Tsukuba Hospital Tsukuba Japan

2. Department of Pharmaceutical Sciences Faculty of Medicine University of Tsukuba Tsukuba Japan

3. Department of Cardiology Faculty of Medicine University of Tsukuba Tsukuba Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13199

Reference28 articles.

1. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society;Page RL;Circulation,2016

2. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society;Al‐Khatib SM;Circulation,2018

3. Monitoring amiodarone’s toxicities: recommendations, evidence, and clinical practice;Stelfox HT;Clin Pharmacol Ther,2004

4. Adverse effects of amiodarone therapy in adults with congenital heart disease;Moore BM;Congenit Heart Dis,2018

5. Guidelines for therapeutic drug monitoring of cardiovascular drugs clinical use of blood drug concentration monitoring (JCS 2015) — digest version;Aonuma K;Circ J,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Incorporating Plasma Lipoprotein Binding into a Physiologically‐Based Pharmacokinetic Model: A Simulation Study with Amiodarone;Clinical Pharmacology & Therapeutics;2023-12-26

2. Use of Therapeutic Drug Monitoring in Amiodarone Treatment: A Systematic Review of Recent Literature;Therapeutic Drug Monitoring;2023-01-11

3. Pharmacokinetics and pharmacodynamics of amiodarone in patients with hypertriglyceridemia: Two case reports;Int. Journal of Clinical Pharmacology and Therapeutics;2022-12-01

4. Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics;European Journal of Pharmaceutical Sciences;2022-07